Physician Editor Kathryn Schwarzenberger, MD, FAAD, spoke with Jonathan Silverberg, MD, PhD, MPH, FAAD, about his JAMA Dermatology article “Efficacy and safety of baricitinib combined with topical corticosteroids for treatment of moderate to severe atopic dermatitis (AD).”
Dr. Silverberg and his colleagues published the results of their study which investigated the efficacy and safety of baricitinib combined with topical corticosteroids for the treatment of moderate to severe AD.
Review the interview at the American Academy of Dermatology.